Bernadette L. Mannaerts

Biometrics Global Clinical R&D
Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserve.

A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserve.

Journal: Reproductive biomedicine online

Published: December 20, 2024

Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research.

Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research.

Journal: Reproductive biomedicine online

Published: August 26, 2024

Corrigendum: Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing.

Corrigendum: Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing.

Journal: Frontiers in endocrinology

Published: March 06, 2024

Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocol.

Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocol.

Journal: Reproductive biology and endocrinology : RB&E

Published: October 14, 2022

Ganirelix and the prevention of premature luteinizing hormone surges.

Ganirelix and the prevention of premature luteinizing hormone surges.

Journal: F&S reports

Published: October 04, 2022

Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing.

Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing.

Journal: Frontiers in endocrinology

Published: July 27, 2022

Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection.

Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection.

Journal: Reproductive biology and endocrinology : RB&E

Published: March 13, 2022

Response to: Comparison between follitropin delta and follitropin alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms!

Response to: Comparison between follitropin delta and follitropin alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms!

Journal: Reproductive biomedicine online

Published: February 14, 2022

A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.

A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.

Journal: Human reproduction (Oxford, England)

Published: October 27, 2021

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution.

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution.

Journal: International journal of clinical pharmacology and therapeutics

Published: October 08, 2021

Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta.

Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta.

Journal: Journal of assisted reproduction and genetics

Published: April 22, 2021

Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.

Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.

Journal: Reproductive biomedicine online

Published: March 30, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026